Literature DB >> 23292163

Increased risk of hip fracture among Japanese hemodialysis patients.

Minako Wakasugi1, Junichiro James Kazama, Masatomo Taniguchi, Atsushi Wada, Kunitoshi Iseki, Yoshiharu Tsubakihara, Ichiei Narita.   

Abstract

Incidence of hip fracture in dialysis patients is significantly higher than that in the general population. As information is lacking about Asian dialysis patients, we compared the incidence of hip fracture in hemodialysis patients with that in the general population in Japan. We conducted a retrospective cohort study using panel data from the Japanese Society for Dialysis Therapy registry. The study included patients without history of hip fracture who received hemodialysis three times per week as of December 31, 2007. We compared the observed number of hip fractures to the expected number derived from a national survey, and calculated standardized incidence ratios (SIRs) and the incidence rate difference. Subgroup analysis was performed according to vintage and diabetic status. During the one-year study period, 1,437 hip fractures were recorded in the 128,141 hemodialysis patients (61.9 % male). The overall incidence was 7.57 and 17.43 per 1,000 person-years in men and women, respectively. The SIRs for male and female patients were 6.2 [95 % confidence interval (CI) 5.7-6.8] and 4.9 (95 % CI 4.6-5.3) compared to the general population, and remained nearly constant until 16 years vintage, but increased steeply thereafter. The incidence rate difference of hip fracture increased with age. The SIRs for diabetics of both genders were higher than those for non-diabetics. Our study provides additional evidence that hip fracture risk among Asian dialysis patients is also significantly higher than in the general population.

Entities:  

Mesh:

Year:  2013        PMID: 23292163     DOI: 10.1007/s00774-012-0411-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  27 in total

1.  Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.

Authors:  M Coco; H Rush
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

2.  Hip axis length in mid-life Japanese and Caucasian U.S. residents: no evidence for an ethnic difference.

Authors:  Gail A Greendale; Jean T Young; Mei-Hua Huang; Alexander Bucur; Yan Wang; Teresa Seeman
Journal:  Osteoporos Int       Date:  2003-04-25       Impact factor: 4.507

3.  PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

Authors:  Mark D Danese; John Kim; Quan V Doan; Michelle Dylan; Robert Griffiths; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

Review 4.  Chronic kidney disease: the global challenge.

Authors:  A Meguid El Nahas; Aminu K Bello
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

5.  Overview of regular dialysis treatment in Japan (as of 31 December 2008).

Authors:  Shigeru Nakai; Kazuyuki Suzuki; Ikuto Masakane; Atsushi Wada; Noritomo Itami; Satoshi Ogata; Naoki Kimata; Takashi Shigematsu; Toshio Shinoda; Tetsuo Syouji; Masatomo Taniguchi; Kenji Tsuchida; Hidetomo Nakamoto; Shinichi Nishi; Hiroshi Nishi; Seiji Hashimoto; Takeshi Hasegawa; Norio Hanafusa; Takayuki Hamano; Naohiko Fujii; Seiji Marubayashi; Osamu Morita; Kunihiro Yamagata; Kenji Wakai; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Ther Apher Dial       Date:  2010-12       Impact factor: 1.762

6.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

8.  A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians.

Authors:  P D Ross; H Norimatsu; J W Davis; K Yano; R D Wasnich; S Fujiwara; Y Hosoda; L J Melton
Journal:  Am J Epidemiol       Date:  1991-04-15       Impact factor: 4.897

9.  Increased risk of hip fracture among men with CKD.

Authors:  Annemarie C Dooley; Noel S Weiss; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2008-01       Impact factor: 8.860

Review 10.  Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD.

Authors:  David Goldsmith; Prajesh Kothawala; Arpi Chalian; Myriam Bernal; Sean Robbins; Adrian Covic
Journal:  Am J Kidney Dis       Date:  2009-06       Impact factor: 8.860

View more
  31 in total

1.  Not only for the risk of bone fracture.

Authors:  Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2015-05-12       Impact factor: 2.626

2.  Fractures in Patients with CKD: Time for Action.

Authors:  Sharon M Moe; Thomas L Nickolas
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 3.  Renal Osteodystrophy or Kidney-Induced Osteoporosis?

Authors:  Sharon M Moe
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

4.  Chronic kidney disease is associated with low BMD at the hip but not at the spine.

Authors:  K S Bezerra de Carvalho; R F V Vasco; M R Custodio; V Jorgetti; R M A Moysés; R M Elias
Journal:  Osteoporos Int       Date:  2019-01-28       Impact factor: 4.507

5.  Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.

Authors:  Kimihiko Goto; Shunsuke Goto; Hideki Fujii; Kentaro Watanabe; Keiji Kono; Shinichi Nishi
Journal:  J Bone Miner Metab       Date:  2019-06-18       Impact factor: 2.626

Review 6.  Uremic Toxicity and Bone in CKD.

Authors:  Suguru Yamamoto; Masafumi Fukagawa
Journal:  J Nephrol       Date:  2017-06-01       Impact factor: 3.902

7.  Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Authors:  Sharon M Moe; Safa Abdalla; Glenn M Chertow; Patrick S Parfrey; Geoffrey A Block; Ricardo Correa-Rotter; Jürgen Floege; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; David C Wheeler; Bastian Dehmel; William G Goodman; Tilman B Drüeke
Journal:  J Am Soc Nephrol       Date:  2014-12-11       Impact factor: 10.121

8.  Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Atsushi Wada; Junichi Hoshino; Ikuto Masakane
Journal:  J Am Soc Nephrol       Date:  2017-11-30       Impact factor: 10.121

9.  The utility of FRAX® in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.

Authors:  J Przedlacki; J Buczyńska-Chyl; P Koźmiński; E Niemczyk; E Wojtaszek; E Gieglis; P Żebrowski; A Podgórzak; J Wściślak; M Wieliczko; J Matuszkiewicz-Rowińska
Journal:  Osteoporos Int       Date:  2018-02-06       Impact factor: 4.507

10.  [Value of serum alkaline phosphatase for predicting 2-year fracture in patients with chronic kidney disease on dialysis].

Authors:  Jianyi Pan; Haitang Hu; Wei Zhang; Jinzhong Chen; Xianrui Dou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.